SEARCH

SEARCH BY CITATION

References

  • 1
    Falk H. Liver. In: SchottenfeldD. FraumeniJJr, eds. Cancer epidemiology and prevention. Philadelphia: Saunders, 1982: 668682.
  • 2
    Bosch FX, Munoz N. Epidemiology of hepatocellular carcinoma. In: BannaschP, KepplerD, WeberG. eds. Liver cell carcinoma. Dordrecht: Kluwer Academic, 1989: 312.
  • 3
    Linsell A. Primary liver cancer: Epidemiology and etiology. In: WaneboHJ. ed. Hepatic and biliary cancer. New York: Dekker, 1987: 315.
  • 4
    Lin TM, Tsu WT, Chen CJ. Mortality of hepatoma and cirrhosis of liver in Taiwan. Br J Cancer 1986; 54: 969976.
  • 5
    Chen CJ, Lee SS, Hsu KH, Tsai SF, You SL, Lin TM. Epidemiologic characteristics of malignant neoplasms in Taiwan: I. All cancer sites. J Natl Public Health Assoc (ROC) 1988; 8: 5971.
  • 6
    Yu MW, Tsai SF, Hsu KH, You SL, Lee SS, Lin TM, Chen CJ. Epidemiologic characteristics of malignant neoplasms in Taiwan: II. liver cancer. J Natl Public Health Assoc (ROC) 1988; 8: 125138.
  • 7
    Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 1982; 2(suppl): 2126.
  • 8
    Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Grit Rev Oncol Hematol 1994; 17: 7191.
  • 9
    Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991; 51: 56215625.
  • 10
    Chang CC, Yu MW, Lu CF, Yang CS, Chen CJ. A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. J Med Virol 1994; 43: 276280.
  • 11
    Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY. et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking, and familial tendency on hepatocellular carcinoma. Hepatology 1991; 13: 398406.
  • 12
    Chen CJ, Yu MW, Wang CJ, Huang HY, Lin WC. Multiple risk factors of hepatocellular carcinoma: a cohort study of 13,737 male adults in Taiwan. J Gastroenterol Hepatol 1993; 8: s83s87.
  • 13
    Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993; 53: 790794.
  • 14
    Yu MW, Hsieh HH, Pan WH, Yang CS, Chen CJ. Vegetable consumption, serum retinol level and risk of hepatocellular carcinoma. Cancer Res 1995; 55: 13011305.
  • 15
    Shank RC, Gordon JE, Wogan GN, Nondasuta A, Subhamani B. Dietary aflatoxins and human liver cancer: III. Field survey of rural Thai families for ingested aflatoxins. Food Cosmet Toxicol 1972; 10: 7184.
  • 16
    Peers FG, Linsell CA. Dietary aflatoxins and liver cancer: a population based study in Kenya. Br J Cancer 1973; 27: 473484.
  • 17
    Peers FG, Gilman GA, Linsell CA. Dietary aflatoxins and human liver cancer: a study in Swaziland. Br J Cancer 1976; 17: 167176.
  • 18
    Peers F, Bosch X, Kaldor J, Linsell A, Pluijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 1987; 39: 545553.
  • 19
    Van Rosenburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van Der Watt JJ, Vincent TJ, Purchase IF. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 1985; 51: 713726.
  • 20
    Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989; 49: 25062509.
  • 21
    Hatch MC, Chen CJ, Levin B, Ji BT, Yang GY, Hsu SW, Wang LW. et al. Urinary aflatoxin levels, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Int J Cancer 1993; 54: 931934.
  • 22
    Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD. et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943946.
  • 23
    Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN. et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarker Prev 1994; 3: 310.
  • 24
    Allen SJ, Wild CP, Riley EM, Montesano R, Bennett S, Whittle HC, Hall AJ. et al. Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hyg 1992; 58: 426430.
  • 25
    Zhang YJ, Chen CJ, Haghighi B, Yang GY, Hsieh LL, Wang LW, Santella RM. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis. Cancer Res 1991; 51: 17201725.
  • 26
    Zhang YJ, Chen CJ, Lee CS, Haghighi B, Yang GY, Wang LW, Feitelson M. et al. Aflatoxin B1-DNA adducts and hepatitis B antigens in hepatocellular carcinoma and non-tumorous liver tissues. Carcinogenesis 1991; 12: 22492252.
  • 27
    Chen CJ, Zhang YJ, Lu SN, Santella RM. Aflatoxin B1 DNA adducts in smeared tumor tissues from patients with hepatocellular carcinoma. Hepatology 1992; 16: 11501155.
  • 28
    Li KG, Li HP, Wong SS, Chuang YS. Survey of aflatoxin contaminations in peanuts from various areas in Taiwan. Taichung: Taiwan Agricultural Chemical and Toxic Substances Research Institute. 1977: 37.
  • 29
    Orti DL, Grainger J, Ashley DL, Hill RH Jr. Chromatographic and spectroscopic properties of hemiacetals of aflatoxin and sterigmatocystin metabolites. J Chromatography 1989; 462: 268279.
  • 30
    Baertschi SW, Raney KD, Stone MP, Harris TM. Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species. J Am Chem Soc 1988; 11: 79297931.
  • 31
    Wild CP, Jiang YZ, Sabbioni G, Chapot B, Montesano R. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res 1990; 50: 245251.
  • 32
    Sheabar FZ, Groopman JD, Qian GS, Wogan GN. Quantitative analysis of aflatoxin-albumin adducts. Carcinogenesis 1993; 14: 12031208.
  • 33
    Dejean A, Bougueleret L, Grzeschik KH, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 1986; 322: 7072.
  • 34
    Benbrook D, Lernhardt E, Pfahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 1988; 333: 669672.
  • 35
    Hino O, Shows TB, Rogler CE. Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17; 18 translocation. Proc Natl Acad Sci USA 1986; 83: 83388342.
  • 36
    Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990; 343: 457461.
  • 37
    Spandau DF, Lee CH. Transactivation of viral enhancers by the hepatitis B virus X protein. J Virol 1988; 62: 427434.
  • 38
    Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317320.
  • 39
    Dragan YP, Pitot HC. Aflatoxin Carcinogenesis in the context of the multistage nature of cancer. In: EatonDL, GroopmanJD. eds. The toxicology of aflatoxins: human health, veterinary, and agricultural significance. San Diego: Academic, 1994: 233258.
  • 40
    Gallagher EP, Wienkers LC, Stapleton PL, Kunze KL, Eaton DL. Role of human microsomal and human complementary DNA-expressed cyto-chromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer Res 1994; 54: 101108.
  • 41
    Kensler TW, Egner PA, Davidson BD, Roebuck BD, Pikul A, Groopman JD. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of reduction of glutathione S-transferase. Cancer Res 1986; 46: 39243931.
  • 42
    Chisari F, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S. et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 11451156.
  • 43
    Wild CP, Garner RC, Montesano R, Tursi F. Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis 1986; 7: 853858.
  • 44
    Sabbioni G, Skipper PL, Buchi G, Tannenbaum SR. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis 1987; 8: 819824.
  • 45
    Breslow NE, Day NE. Statistical methods in cancer research. Vol. I. The analysis of case-control study. Lyon: International Agency for Research on Cancers. 1980: 291.
  • 46
    Puisieux A, Lim S, Groopman J, Ozturk M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res 1991; 51: 61856189.
  • 47
    Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427428.
  • 48
    Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from South Africa. Nature 1991; 350: 429431.